ÂÜÀòÂÒÂ×

As President of WCG’s Study Planning and Site Optimization group, Jill is responsible for developing strategy, driving the vision, and delivering for customers as WCG continues to drive ingenuity in the clinical research space as it relates to site identification, selection, and activation. The aim is to deliver transformational site activation solutions that stimulate growth, foster compliance, and maximize efficiency for those who perform clinical trials. With over 25 years in clinical research, Jill is an expert in clinical business strategy, transformation, innovation, pharmaceutical efficiency, and clinical research operations.

Prior to WCG, Jill was the vice president of Vault Clinical at Veeva. Jill was responsible for providing thought leadership, driving development of product and market strategy, and coordinating resources across the customer lifecycle from sales to delivery for eMF, Study Startup and CTMS.

Before joining Veeva, Jill spent the majority of her career at Covance, where she held a variety of strategic roles in clinical operations, project management, and as a Six Sigma Black Belt. She spent the early part of her career running large, global clinical trials in oncology, cardiovascular, metabolic, and neurology compounds. As she moved into more strategic roles, she provided executive level guidance and led a team of scientific, operational, and medical experts to bring about customized, practical and evidence-based solutions.

Jill holds a BSc in Biology from SUNY – Environmental Science and Forestry and is an instructor for clinical monitoring at Mercer County College, supporting Drexel University’s Clinical Development Master program. She was previously the founding president of the ACRP Chapter in the Greater Philadelphia area, and is a frequent speaker at industry conferences.